lacosamide oral solution
Generic: lacosamide
Labeler: kesin pharma corporationDrug Facts
Product Profile
Brand Name
lacosamide oral solution
Generic Name
lacosamide
Labeler
kesin pharma corporation
Dosage Form
SOLUTION
Routes
Active Ingredients
lacosamide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
81033-428
Product ID
81033-428_446f14ca-a469-dd4c-e063-6394a90a1fe4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA219699
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2025-07-14
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
81033428
Hyphenated Format
81033-428
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide oral solution (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA219699 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 200 mL in 1 BOTTLE, PLASTIC (81033-428-02)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "446f14ca-a469-dd4c-e063-6394a90a1fe4", "openfda": {"nui": ["N0000008486"], "upc": ["0381033428024"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["446f14be-5d79-26b9-e063-6294a90ae0b5"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Kesin Pharma Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "200 mL in 1 BOTTLE, PLASTIC (81033-428-02)", "package_ndc": "81033-428-02", "marketing_start_date": "20250714"}], "brand_name": "Lacosamide Oral Solution", "product_id": "81033-428_446f14ca-a469-dd4c-e063-6394a90a1fe4", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "81033-428", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Kesin Pharma Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA219699", "marketing_category": "ANDA", "marketing_start_date": "20250714", "listing_expiration_date": "20261231"}